Skip to content

Zymeworks ZYME Earnings yield

Earnings yield at other companies

Pfizer logo
PfizerPFE
6.8%
Amgen logo
AmgenAMGN
4.1%+0.6pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-9.9%-2.8pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-18%-4.7pp
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-13.6%-4.3pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-8.8%-22.8pp

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Calculated from Zymeworks’s reported figures.

Based on trailing twelve months.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's earnings yield?
Zymeworks (ZYME) reported earnings yield of -5.5% in Q1 2026.
How has Zymeworks's earnings yield changed year-over-year?
Zymeworks's earnings yield increased by 59.8% year-over-year, from -13.7% to -5.5%.
What is the long-term trend for Zymeworks's earnings yield?
Over 5 years (2020 to 2025), Zymeworks's earnings yield has grown at a -13.0% compound annual growth rate (CAGR), from -8.2% to -4.1%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.